Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate For 7 (3) For The Period 31St March 2019
Compliance Certificate for 7 (3) for the period 31st March 201919-04-2019
Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate For 7 (3) For The Period 31St March 2019
Compliance Certificate for 7 (3) for the period 31st March 2019Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- DHIRAJ RATHIDesignation :- Company Secretary and Compliance OfficerNath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended March 31, 2019
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click hereNath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Corporate PresentationNath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release in Connection with retirement of Nandkishor Kagliwal from the BoardNath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Retirement
Intimation of Retirement from the board of directorsNath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akash Farms Pvt LtdNath Bio-Genes (India) Ltd - 537291 - Press Release For The Financial Results For 31St December 2018
Press Release for the financial results for 31st December 2018Nath Bio-Genes (India) Ltd - 537291 - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2018
Unaudited Financial Results for the quarter and nine months ended 31st December 2018